Biden proposes requiring Medicare, Medicaid to cover weight loss drugs
In order to combat obesity, the Biden administration intends to mandate that Medicare and Medicaid provide coverage for weight-loss drugs.
Proposed by the administration on Tuesday, the new rule would significantly increase access to anti-obesity drugs such as Mounjaro, Ozempic, and Wegovy.
These medications have only been covered by Medicare and Medicaid up until now when they are used to treat diseases like diabetes.
The modification would significantly lower the medications' out-of-pocket expenses. According to a White House official, the cost of a month's supply of weight loss medications might now reach $1,000 or higher.
Over 40% of Americans are categorized as obese. The Centers for Disease Control and Prevention state that obesity is a chronic disease that increases the risk of hear...